| Literature DB >> 33841543 |
Roya Pournejati1,2, Ronald Gust2, Brigitte Kircher3,4, Hamid Reza Karbalaei-Heidari1.
Abstract
Screening of bioactive compounds with potential binding affinity to DNA as one of the target molecules in fighting againstEntities:
Keywords: DNA damage; Hepatocellular carcinoma; Microbacterium sp.; Microindoline; Natural products
Year: 2020 PMID: 33841543 PMCID: PMC8019894 DOI: 10.22037/ijpr.2020.111982.13469
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Experimental results for 2 level fractional factorial design
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 0.65 | 0.89 ± 1.47 | +1 | -1 | -1 | -1 | -1 | 1 |
| 5.17 | 4.99 ± 2.12 | -1 | -1 | -1 | -1 | +1 | 2 |
| 24.74 | 38.3 ± 16.9 | -1 | -1 | -1 | +1 | -1 | 3 |
| 82.02 | 91.07 ± 0.68 | +1 | -1 | -1 | +1 | +1 | 4 |
| 23.2 | 48.51 ± 10.35 | -1 | -1 | +1 | -1 | -1 | 5 |
| 71.49 | 81.62 ± 15.34 | +1 | -1 | +1 | -1 | +1 | 6 |
| 31.29 | 95.04 ± 0.43 | +1 | -1 | +1 | +1 | -1 | 7 |
| 50.06 | 61.06 ± 15.66 | -1 | -1 | +1 | +1 | +1 | 8 |
| 21.75 | 28.48 ± 5.42 | -1 | +1 | -1 | -1 | -1 | 9 |
| 1.2 | 2.13 ± 1.4 | +1 | +1 | -1 | -1 | +1 | 10 |
| 8.53 | 13.33 ± 3.33 | +1 | +1 | -1 | +1 | -1 | 11 |
| 53.45 | 87.81 ± 5.86 | -1 | +1 | -1 | +1 | +1 | 12 |
| 42.46 | 91.16 ± 3.66 | +1 | +1 | +1 | -1 | -1 | 13 |
| 69.91 | 91.51 ± 5.07 | -1 | +1 | +1 | -1 | +1 | 14 |
| 8.45 | 11.94 ± 2.17 | -1 | +1 | +1 | +1 | -1 | 15 |
| 88.89 | 88.9 ± 6.012 | +1 | +1 | +1 | +1 | +1 | 16 |
The spherical central composite design (CCD) including percentages of “Cell death”, “Response” and “Predicted response”.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 7.72 | 9.22 | 15.64 ± 3.55 | -1 | -1 | -1 | 1 |
| 48.84 | 52.96 | 98.53 ± 1.73 | -1 | -1 | +1 | 2 |
| 55.54 | 62.45 | 97.34 ± 2.51 | -1 | +1 | -1 | 3 |
| 78.16 | 83.08 | 98.45 ± 1.63 | -1 | +1 | +1 | 4 |
| 18.88 | 18.64 | 40.32 ± 4.56 | +1 | -1 | -1 | 5 |
| 21.04 | 20.24 | 23.51 ± 4.85 | +1 | -1 | +1 | 6 |
| 25.08 | 25.63 | 50.98 ± 3.54 | +1 | +1 | -1 | 7 |
| 11.24 | 14.4 | 32.8 ± 1.95 | +1 | +1 | +1 | 8 |
| 22.62 | 19.38 | 27.05 ± 2.01 | 0 | 0 | -1.73 | 9 |
| 46.22 | 44.89 | 64.52 ± 1.1 | 0 | 0 | +1.73 | 10 |
| 21.83 | 17.65 | 37.24 ± 4.87 | 0 | -1.73 | 0 | 11 |
| 43.05 | 40.64 | 70.32 ± 0.2 | 0 | +1.73 | 0 | 12 |
| 58.18 | 49.93 | 49.93 ± 14.24 | -1.73 | 0 | 0 | 13 |
| 9.94 | 11.61 | 16.21 ± 7.32 | +1.73 | 0 | 0 | 14 |
| 78.37 | 73.42 | 99.24 ± 0.1 | 0 | 0 | 0 | 15 |
| 78.37 | 75 | 95.41 ± 4.27 | 0 | 0 | 0 | 16 |
| 78.37 | 80.43 | 97.31 ± 2.67 | 0 | 0 | 0 | 17 |
| 78.37 | 83.36 | 97.45 ± 3.39 | 0 | 0 | 0 | 18 |
| 78.37 | 75.74 | 97.07 ± 2.03 | 0 | 0 | 0 | 19 |
| 78.37 | 82.24 | 97.45 ± 3.02 | 0 | 0 | 0 | 20 |
Figure 1Carbon and nitrogen source selection experiment. Microbacterium sp. RP 581 biomass and the organic extract production with respect to media number
Figure 23D graph of three independent variables and their interaction in RSM experiments
Figure 31H NMR spectra and proposed structure of Microindoline 581
Figure 4Fluorescence spectra of Microindoline 581 and F-DNA interaction. The Microindoline 581 (90 µM) was incubated with a range of F-DNA concentration (0-172 µM). The Stern –Volmer plot of binding was drawn
Figure 5Gel electrophoresis (1% agarose) of plasmid DNA treated with Microindoline 581; a) lane 1, DNA + H2O2 (50 µM) (negative control), lanes 3-7, DNA + H2O2 (50 µM) treated with 1.5 mM, 2 mM, 2.5 mM, 3 mM and 6 mM of Microindoline 581, respectively, at 37 °C for 1 h; b) lane 2, DNA + H2O2 (50 µM) (negative control), lanes 3-9, DNA + H2O2 (50 µM) treated with 300 µM of Microindoline 581, 1 h, 3 h, 6 h, 9 h, 16 h, 20 h and 24 h, 37 °C respectively; c) lane 1, DNA + H2O2 (50 µM) + 1.5 mM of Microindoline 581, lane 2, DNA + H2O2 (50 µM) + 1.5 mM of Microindoline 581 + 100 µM of DMSO, lane 3, DNA + H2O2 (50 µM) + 1.5 mM of Microindoline 581+ 100 µM of KI, lane 4, DNA + H2O2 (50 µM) + 1.5 mM of Microindoline 581 + 100 µM of EDTA, lane 5, DNA + H2O2 (50 µM) + 1.5 mM of Microindoline 581 + 100 µM of NaN3, lane 6 DNA + 1.5 mM of Microindoline 581 and lane 7, DNA + H2O2 (50 µM) (negative control)
Figure 6. )a) Cell viability determined by MTT assay. Various cancer cell lines were treated with Microindoline 581 (600 µM) for 48 h. The mean viability ± STD of three experiments is shown. Cellular viability in the absence of the compound was set at 100% and) b) Cellular viability of HepG2 cells. Cell viability percentage was determined by MTT and crystal violet assay after treatment with various concentrations of Microindoline 581 for 48 h
Figure 7HepG2 cells migration analysis using scratch assay )a) Control group, )b) HepG2 cells treated with 90 µM of Microindoline 581
Cell death induction in HepG2 cells treated with Microindoline 581 for 24 h
|
|
|
|
|
|
|---|---|---|---|---|
| 0 | 2.95 ± 1.05 | 10.05 ± 0.05 | 2.55 ± 0.25 | 84.35 ± 1.15 |
| 90 | 7.95*** ± 1.05 | 10.80 ± 1.70 | 2.20 ± 0.30 | 79.05* ± 0.35 |
| 147 | 4.9** ± 1.7 | 15.6** ± 0.80 | 13.15** ± 4.25 | 66.35** ± 1.75 |
| 172 | 22.55*** ± 4.65 | 8.45 ± 1.55 | 1.75 ± 0.05 | 67.25** ± 3.05 |
*p-value < 0.05, ** p-value < 0.005, *** p-value < 0.0005.